BACKGROUND: Cancers of the upper gastrointestinal tract remain a significant cause of morbidity and mortality. Cysteine, known to be involved in a myriad of immuno-modulatory, anti-oxidant, and anti-carcinogenic pathways, has not been investigated in the aetiology of oesophageal or gastric cancers. To examine the relationship between serum cysteine concentration and risk of these cancers we conducted a nested case-cohort study within the General Population Nutrition Intervention Trial in Linxian, China. METHODS: 498 oesophageal squamous cell carcinomas (OSCCs) and 255 gastric cardia adenocarcinomas (GCAs) were matched by age and sex to 947 individuals from the wider cohort. We calculated HRs and 95% CIs using the case-cohort estimator for the Cox proportional hazards models, stratified on age and sex, with adjustment for potential confounders. RESULTS: Higher concentrations of serum cysteine were significantly associated with a lower risk of both OSCC and GCA. For those in the highest quartile of serum cysteine, compared to those in the lowest, the multivariate HRs were 0.70 for OSCC (95% CI 0.51 to 0.98) and 0.59 for GCA (95% CI 0.38 to 0.91). These associations were dose dependent (p for trend=0.006 and 0.008, respectively). These inverse associations were not significantly modified by other risk factors, with the exception of age, where a stronger association was noted among persons in the older age strata. CONCLUSION: Higher serum concentrations of cysteine were associated with a significantly reduced risk of OSCC and GCA. Cysteine should be further investigated for its potential as a chemopreventive agent for upper gastrointestinal cancers.
BACKGROUND:Cancers of the upper gastrointestinal tract remain a significant cause of morbidity and mortality. Cysteine, known to be involved in a myriad of immuno-modulatory, anti-oxidant, and anti-carcinogenic pathways, has not been investigated in the aetiology of oesophageal or gastric cancers. To examine the relationship between serum cysteine concentration and risk of these cancers we conducted a nested case-cohort study within the General Population Nutrition Intervention Trial in Linxian, China. METHODS: 498 oesophageal squamous cell carcinomas (OSCCs) and 255 gastric cardia adenocarcinomas (GCAs) were matched by age and sex to 947 individuals from the wider cohort. We calculated HRs and 95% CIs using the case-cohort estimator for the Cox proportional hazards models, stratified on age and sex, with adjustment for potential confounders. RESULTS: Higher concentrations of serum cysteine were significantly associated with a lower risk of both OSCC and GCA. For those in the highest quartile of serum cysteine, compared to those in the lowest, the multivariate HRs were 0.70 for OSCC (95% CI 0.51 to 0.98) and 0.59 for GCA (95% CI 0.38 to 0.91). These associations were dose dependent (p for trend=0.006 and 0.008, respectively). These inverse associations were not significantly modified by other risk factors, with the exception of age, where a stronger association was noted among persons in the older age strata. CONCLUSION: Higher serum concentrations of cysteine were associated with a significantly reduced risk of OSCC and GCA. Cysteine should be further investigated for its potential as a chemopreventive agent for upper gastrointestinal cancers.
Authors: Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang Journal: Int J Cancer Date: 2009-03-15 Impact factor: 7.396
Authors: Jennifer Lin; I-Min Lee; Yiqing Song; Nancy R Cook; Jacob Selhub; JoAnn E Manson; Julie E Buring; Shumin M Zhang Journal: Cancer Res Date: 2010-03-02 Impact factor: 12.701
Authors: A Izzotti; R M Balansky; F Dagostini; C Bennicelli; S R Myers; C J Grubbs; R A Lubet; G J Kelloff; S De Flora Journal: Cancer Res Date: 2001-03-15 Impact factor: 12.701
Authors: Alberto Izzotti; George A Calin; Vernon E Steele; Cristina Cartiglia; Mariagrazia Longobardi; Carlo M Croce; Silvio De Flora Journal: Cancer Prev Res (Phila) Date: 2010-01
Authors: Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor Journal: Int J Cancer Date: 2005-01-20 Impact factor: 7.396
Authors: Eugenia H Miranti; Neal D Freedman; Stephanie J Weinstein; Christian C Abnet; Jacob Selhub; Gwen Murphy; Lena Diaw; Satu Männistö; Philip R Taylor; Demetrius Albanes; Rachael Z Stolzenberg-Solomon Journal: Am J Clin Nutr Date: 2016-08-17 Impact factor: 7.045
Authors: He Liang; Zhao Yang; Jian-Bing Wang; Pei Yu; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor Journal: Thorac Cancer Date: 2017-09-20 Impact factor: 3.500